A Study to Evaluate the Safety and Efficacy of 2ccPA in Patients With Symptomatic Knee Osteoarthritis

NCT05807529 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis, Knee

Interventions

DRUG: 2ccPA
DRUG: Placebo

Sponsor

Orient Europharma Co., Ltd.